BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23800350)

  • 1. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
    Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
    J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
    Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
    J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Conforti P; Cattaneo E; Buckley NJ
    J Neurochem; 2011 Feb; 116(3):415-25. PubMed ID: 21105876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
    Bithell A; Johnson R; Buckley NJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones.
    Schiffer D; Caldera V; Mellai M; Conforti P; Cattaneo E; Zuccato C
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):899-910. PubMed ID: 24634989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.
    Conforti P; Mas Monteys A; Zuccato C; Buckley NJ; Davidson B; Cattaneo E
    Gene Ther; 2013 Jun; 20(6):678-85. PubMed ID: 23151521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease.
    Marullo M; Valenza M; Mariotti C; Di Donato S; Cattaneo E; Zuccato C
    Brain Pathol; 2010 Jan; 20(1):96-105. PubMed ID: 19134002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
    J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
    Zuccato C; Tartari M; Crotti A; Goffredo D; Valenza M; Conti L; Cataudella T; Leavitt BR; Hayden MR; Timmusk T; Rigamonti D; Cattaneo E
    Nat Genet; 2003 Sep; 35(1):76-83. PubMed ID: 12881722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target.
    Rigamonti D; Mutti C; Zuccato C; Cattaneo E; Contini A
    Curr Pharm Des; 2009; 15(34):3958-67. PubMed ID: 19751206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmids containing NRSE/RE1 sites enhance neurite outgrowth of retinal ganglion cells via sequestration of REST independent of NRSE dsRNA expression.
    Koch JC; Barski E; Lingor P; Bähr M; Michel U
    FEBS J; 2011 Sep; 278(18):3472-83. PubMed ID: 21790997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators.
    Rigamonti D; Bolognini D; Mutti C; Zuccato C; Tartari M; Sola F; Valenza M; Kazantsev AG; Cattaneo E
    J Biol Chem; 2007 Aug; 282(34):24554-62. PubMed ID: 17565993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.
    Charbord J; Poydenot P; Bonnefond C; Feyeux M; Casagrande F; Brinon B; Francelle L; Aurégan G; Guillermier M; Cailleret M; Viegas P; Nicoleau C; Martinat C; Brouillet E; Cattaneo E; Peschanski M; Lechuga M; Perrier AL
    Stem Cells; 2013 Sep; 31(9):1816-28. PubMed ID: 23712629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.
    Packer AN; Xing Y; Harper SQ; Jones L; Davidson BL
    J Neurosci; 2008 Dec; 28(53):14341-6. PubMed ID: 19118166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease.
    Leone S; Mutti C; Kazantsev A; Sturlese M; Moro S; Cattaneo E; Rigamonti D; Contini A
    Bioorg Med Chem; 2008 May; 16(10):5695-703. PubMed ID: 18406155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation.
    Tabuchi A; Yamada T; Sasagawa S; Naruse Y; Mori N; Tsuda M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):415-20. PubMed ID: 11779185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.